Created at	Source	Raw Value	Validated value
July 8, 2021, 4 a.m.	usa	Geometric mean fold rise (GMFR) of SARS-Cov-2 neutralising antibodies to B.1.351 variant;Geometric mean titer (GMT) of SARS-CoV-2 neutralising antibodies to B.1.351 variant;Proportion of subjects achieving seroconversion of SARS-CoV-2 neutralising antibodies to B.1.351 variant	Geometric mean fold rise (GMFR) of SARS-Cov-2 neutralising antibodies to B.1.351 variant;Geometric mean titer (GMT) of SARS-CoV-2 neutralising antibodies to B.1.351 variant;Proportion of subjects achieving seroconversion of SARS-CoV-2 neutralising antibodies to B.1.351 variant